Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Recombinant dna technique included in method of making a...
Reexamination Certificate
2011-05-24
2011-05-24
Shafer, Shulamith H (Department: 1647)
Chemistry: molecular biology and microbiology
Micro-organism, tissue cell culture or enzyme using process...
Recombinant dna technique included in method of making a...
C435S006120, C435S325000, C536S023500, C536S024100
Reexamination Certificate
active
07947469
ABSTRACT:
Disclosed herein are methods and compositions for modulating HIV infection by regulating expression of one or more receptors.
REFERENCES:
patent: 5789538 (1998-08-01), Rebar et al.
patent: 6007988 (1999-12-01), Choo et al.
patent: 6013453 (2000-01-01), Choo et al.
patent: 6140081 (2000-10-01), Barbas
patent: 6140466 (2000-10-01), Barbas, III et al.
patent: 6242568 (2001-06-01), Barbas, III et al.
patent: 6453242 (2002-09-01), Eisenberg et al.
patent: 6534261 (2003-03-01), Cox, III et al.
patent: 6607882 (2003-08-01), Cox, III et al.
patent: 6689877 (2004-02-01), Ikezu et al.
patent: 7067317 (2006-06-01), Rebar et al.
patent: 2002/0061512 (2002-05-01), Kim et al.
patent: 2002/0165356 (2002-11-01), Barbas, III et al.
patent: 2003/0082561 (2003-05-01), Sera
patent: 2003/0134350 (2003-07-01), Sera
patent: WO 96/06166 (1996-02-01), None
patent: WO 96/32475 (1996-10-01), None
patent: WO 98/53057 (1998-11-01), None
patent: WO 98/53058 (1998-11-01), None
patent: WO 98/53059 (1998-11-01), None
patent: WO 98/53060 (1998-11-01), None
patent: WO 99/42474 (1999-08-01), None
patent: WO 99/45132 (1999-09-01), None
patent: WO 99/47656 (1999-09-01), None
patent: WO 00/23464 (2000-04-01), None
patent: WO 00/27878 (2000-05-01), None
patent: WO 00/41566 (2000-07-01), None
patent: WO 00/42219 (2000-07-01), None
patent: WO 02/42459 (2002-05-01), None
patent: WO 02/066640 (2002-08-01), None
patent: WO 03/016496 (2003-02-01), None
Connor et al. 1997. J Exp Med. 185:621-628.
Pohlman et al. 2006. Current Pharm Design. 12:1963-1973.
Phillips, A. 2001 J Pharm Pharmacology 53: 1169-1174.
Starr-Spires et al. 2002. Clin Lab Med 22:681-701.
Thiesen, H. 1996. Gene Expression. 5:229-243.
Romano 2003. Drug News Perspect. 16:267-276.
Hosokawa et al. 2001. BBRC 283:563-568.
Unutmaz et al. 1998. Seminars in Immunology.
Hunt et al 2002. Science 297:415-416.
U.S. Appl. No. 09/718,538, filed Nov. 22, 2000, Choo et al.
Sangamo BioSciences Signs Definitive Agreement to Acquire Gendaq Ltd., Richmond, CA, Jun. 28, 2001.
Sangamo BioSciences, Inc. Completes Gendaq Ltd. Acquisition, Richmond, CA, Jul. 5, 2001.
Dai, et al., “Engineered Zinc Finger-Activating Vascular Endothelial Growth Factor Transcription Factor Plasmid DNA Induces Therapeutic Angiogenesis in Rabbits With Hindlimb Ischemia,”Circulation110:2467-2475 (2004).
Price, et al., “Gene Transfer of an Engineered Transcription Factor Promoting Expression of VEGF-A Protects Against Experimental Diabetic Neuropathy,”Diabetes55:1847-1854 (2006).
Rebar, et al., “Induction of Angiogenesis in a Mouse Model Using Engineered Transcription Factors,”Nature Medicine8:1427-1432 (2002).
Choo Yen
Demaison Christophe
Girdlestone John
Isalan Mark
Moore Michael
Gendaq Ltd.
Pasternak Dahna S.
Robins & Pasternak LLP
Shafer Shulamith H
LandOfFree
Modulation of HIV infection does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Modulation of HIV infection, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modulation of HIV infection will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2674918